The U.S. and China agreed to cooperate on fentanyl, but progress is proving hard to come by.
U.S. Deputy Assistant to the President and Deputy Homeland Security Advisor Jen Daskal, second from left, and Chinese Minister of Public Security Wang Xiaohong, second from right, meeting at the Diaoyutai State Guesthouse in Beijing, January 30, 2024. Credit: Ng Han Guan via AP Photos
In late January, officials from the U.S. and China convened in Beijing to discuss an enduring sticking point in the relationship, as well as a deadly public health crisis across America: fentanyl trafficking.
On paper, the new working group represents a bright spot amid darkening Sino-American tensions and a positive step towards addressing fentanyl-related deaths, which continue to surge. Last year, U.S. overdose fatalities reached 105,000, with the vast majority involving opioids like fenta
Exclusive longform investigative journalism, Q&As, news and analysis, and data on Chinese business elites and corporations. We publish China scoops you won't find anywhere else.
A weekly curated reading list on China from Andrew Peaple.
A daily roundup of China finance, business and economics headlines.
We offer discounts for groups, institutions and students. Go to our Subscriptions page for details.
At the height of the pandemic, Chinese vaccine maker Sinovac was a hero and one of the country’s most promising companies. But its success masked a protracted dispute between rival investors and management for control of the cash-rich company. The Wire China investigates what went wrong.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OKPrivacy policy
